Promoter and Institution shareholding changes align with sector averages, indicating stability with no significant buying or selling activity.

Institutional investments in Sun Pharma have increased slightly QoQ by 1.05%, suggesting a positive outlook amidst sector stability.

Despite the lack of drastic movement, the stock's performance reflects sector trends, particularly against the backdrop of the best (SUDARSHAN) and worst (SHUKRAPHAR) movers.